© Springer-Verlag Berlin Heidelberg 2014Hans Geinitz, Mack Roach III and Nicholas van As (eds.)Radiotherapy in Prostate CancerMedical Radiology10.1007/174_2013_949 Prophylactic Treatment of the Pelvic Lymphatics: Contra Pascal Pommier1 (1) Radiotherapy Department, Centre Léon Bérard, 28 Rue Laënnec,…
First author Study design Key findings Asbell et al. (1988) and Hanks et al. (1991) Eligible patients (pts) had A2 (occult disease >3 + chips & poorly differentiated) and Stage B without clinical…
CT Rectum (Dose in cGy/fx) Bladder (Dose in cGy/fx) Femoral heads (Dose in cGy/fx) Diagnostic multidetector CT 1.74 1.83 4.05 kV CBCT 1.70 1.73 3.14 MVCT 1.05 1.04 1.02 2…
Huang EH, Pollack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321PubMed Huang GJ, Sadetsky…
Fig. 1 Endorectal balloon filled with 40 ml air (left) and deflated (right) QLrad B.V.®, Netherland: is made of silicon, filled with 80 cc of air resulting in a diameter up to 6 cm….
Risk group Low Intermediate High NCCN T-Stage cT1c + cT2a and cT2b − 2c and/or cT3 or PSA <10 ng/ml and >10–20 ng/ml and/or >20 ng/ml or Gleason sum <7 =7 8–10 D’Amico et al. (1997a, 1998,…
Trial Eligibility Arms DFS (%) OS (%) RTOG 85-31 T3 or T1-2, N+ or pT3 RT versus RT + ADT 10 years 23 versus 37 (P < 0.0001) 10 years 39 versus 49 (P = 0.002)…
© Springer-Verlag Berlin Heidelberg 2014Hans Geinitz, Mack Roach III and Nicholas van As (eds.)Radiotherapy in Prostate CancerMedical Radiology10.1007/174_2014_1008 Value of Patient Immobilization in External Beam Radiotherapy for Prostate Cancer Matthias Guckenberger1 (1) Department of Radiation Oncology,…
